
FDA Approved New Monthly Schizophrenia Injection
The agency cleared Teva Pharmaceuticals' WELTRUZA for the treatment of schizophrenia in adults.
Live Poll
Do you trust that pharmaceutical companies prioritize patient needs when developing new long-term medication treatments?














